SpringWorks Therapeutics, Inc. (CIK: 0001773427) EDGAR, Information, Filings... CompaniesBIO.Com

SpringWorks Therapeutics, Inc.

Mailing address
100 WASHINGTON BOULEVARD, STAMFORD, Delaware, 06902
Phone
203-883-9490
State location
Connecticut
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Filings
N/A

SpringWorks Therapeutics, Inc. (CIK: 0001773427) is an American company incorporated in the state of Connecticut. Head office is located at 100 WASHINGTON BOULEVARD, STAMFORD, Connecticut, 06902. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). SpringWorks Therapeutics, Inc. is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
Lin Tai-An	0001991985	Sep-11-2023	officer: Chief Scientific Officer
Cassidy James	0001949023	Oct-06-2022	officer: Chief Medical Officer
ALBAN CARLOS	0001474632	Jul-14-2022	director
Burgess Michael F.	0001801745	May-10-2021	officer: Head of Research & Development
Ashar Bhavesh	0001849740	Mar-22-2021	officer: Chief Commercial Officer
ORBIMED ADVISORS LLC	0001055951	Mar-01-2021	10 percent owner
OrbiMed Capital GP VI LLC	0001682115	Mar-01-2021	10 percent owner
Pichl Daniel	0001819465	Aug-03-2020	officer: Chief People Officer
LYNCH DANIEL	0001177082	May-20-2020	director, 10 percent owner
Fuhrman Alan	0001303521	May-20-2020	director
Lewis-Hall Freda C	0001437909	May-20-2020	director, 10 percent owner
Hambleton Julie	0001578771	May-20-2020	director
SQUINTO STEPHEN P	0001231954	Mar-12-2020	director, 10 percent owner
Francis Perier I Jr	0001304404	Mar-02-2020	officer: Chief Financial Officer
Islam Saqib	0001575408	Mar-02-2020	director, officer: Chief Executive Officer
Edris Badreddin	0001786966	Mar-02-2020	officer: Chief Business Officer
Renstrup Jens	0001786967	Mar-02-2020	officer: Chief Medical Officer
Smith L. Mary	0001787013	Mar-02-2020	officer: See Remarks
Weinstein Herschel S	0001349008	Jan-27-2020	officer: General Counsel & Secretary
Nofi Michael	0001705477	Nov-11-2019	officer: Chief Accounting Officer
PFIZER INC	0000078003	Sep-12-2019	10 percent owner
PATRICK DEVAL L	0001053466	Sep-12-2019	director
GORDON CARL L	0001282930	Sep-12-2019	director, 10 percent owner
Koppel Adam	0001578965	Sep-12-2019	10 percent owner
Schwartz Jeffrey Lawrence	0001702957	Sep-12-2019	director, 10 percent owner
Bain Capital Life Sciences Investors, LLC	0001703031	Sep-12-2019	10 percent owner
Pfizer Ventures (US) LLC	0001776087	Sep-12-2019	10 percent owner
BC SW, LP	0001786351	Sep-12-2019	10 percent owner
Greco Michael V.	0001786766	Sep-12-2019	officer: General Counsel & Secretary

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by SpringWorks Therapeutics, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
SCHEDULE 13G/A	Document	Acc-no: 0000886982-25-001461 (34 Act) Size: KB	Nov-12-2025	005-91134 251472167
SCHEDULE 13G	Document	Acc-no: 0000769993-25-000469 (34 Act) Size: KB	Aug-13-2025	005-91134 251213074
SCHEDULE 13G	Document	Acc-no: 0001393825-25-000056 (34 Act) Size: KB	Aug-08-2025	005-91134 251198774
15-12G	Document	Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0001104659-25-067089 (34 Act) Size: KB	Jul-11-2025	001-39044 251117433
SCHEDULE 13G	Document	Acc-no: 0001076809-25-000072 (34 Act) Size: KB	Jul-07-2025	005-91134 251107982
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-25-065322 ( Act) Size: 0 KB	Jul-02-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-25-065321 ( Act) Size: 0 KB	Jul-02-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-25-065318 ( Act) Size: 0 KB	Jul-02-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-25-065315 ( Act) Size: 0 KB	Jul-02-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-25-065312 ( Act) Size: 0 KB	Jul-02-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-25-065310 ( Act) Size: 0 KB	Jul-02-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-25-065307 ( Act) Size: 0 KB	Jul-02-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-25-065305 ( Act) Size: 0 KB	Jul-02-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-25-065304 ( Act) Size: 0 KB	Jul-02-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-25-065303 ( Act) Size: 0 KB	Jul-02-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-25-065302 ( Act) Size: 0 KB	Jul-02-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-25-065300 ( Act) Size: 0 KB	Jul-02-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-25-065299 ( Act) Size: 0 KB	Jul-02-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-25-065298 ( Act) Size: 0 KB	Jul-02-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-25-065297 ( Act) Size: 0 KB	Jul-02-2025

Recent 20 filings. View all SpringWorks Therapeutics, Inc. filings

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

SpringWorks Therapeutics, Inc. overview
SpringWorks Therapeutics, Inc. job
SpringWorks Therapeutics, Inc. stock
SpringWorks Therapeutics, Inc. ownership
SpringWorks Therapeutics, Inc. CEO
SpringWorks Therapeutics, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.